Back to search
FDAFDA · Food and drugs·Recall number D-0839-2026

Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.

Published September 9, 2026 · Recall initiated: August 17, 2026

Summary

FDA records drug Class II recall D-0839-2026, published September 9, 2026 and initiated August 17, 2026. Recalling firm: Mylan Pharmaceuticals Inc; Status: Ongoing; Reported quantity: 47,662 bottles; Lot: Lot #: 3225272, Exp. September 30, 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

What to do

Voluntary: Firm initiated · Letter

Get an email if PRASUGREL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRASUGREL
Manufacturer
Mylan Pharmaceuticals Inc
Distributor
Nationwide within the U.S
UPC
0303785185932
Lot
Lot #: 3225272, Exp. September 30, 2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93. recalled?

Yes. FDA published recall D-0839-2026 on September 9, 2026. Reported hazard: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRASUGREL. UPC: 0303785185932.